Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide

Stock Information for Seelos Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.